These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9054878)

  • 1. Gastrointestinal cancer after treatment of Hodgkin's disease.
    Birdwell SH; Hancock SL; Varghese A; Cox RS; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):67-73. PubMed ID: 9054878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer after treatment of Hodgkin's disease.
    Hancock SL; Tucker MA; Hoppe RT
    J Natl Cancer Inst; 1993 Jan; 85(1):25-31. PubMed ID: 8416252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of second cancers in patients treated for Hodgkin's disease.
    Boivin JF; Hutchison GB; Zauber AG; Bernstein L; Davis FG; Michel RP; Zanke B; Tan CT; Fuller LM; Mauch P
    J Natl Cancer Inst; 1995 May; 87(10):732-41. PubMed ID: 7563150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second cancer risk following Hodgkin's disease: a 20-year follow-up study.
    van Leeuwen FE; Klokman WJ; Hagenbeek A; Noyon R; van den Belt-Dusebout AW; van Kerkhoff EH; van Heerde P; Somers R
    J Clin Oncol; 1994 Feb; 12(2):312-25. PubMed ID: 8113838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment.
    Swerdlow AJ; Barber JA; Hudson GV; Cunningham D; Gupta RK; Hancock BW; Horwich A; Lister TA; Linch DC
    J Clin Oncol; 2000 Feb; 18(3):498-509. PubMed ID: 10653865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.
    Mauch PM; Kalish LA; Marcus KC; Coleman CN; Shulman LN; Krill E; Come S; Silver B; Canellos GP; Tarbell NJ
    Blood; 1996 May; 87(9):3625-32. PubMed ID: 8611686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
    Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
    N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease.
    Henry-Amar M
    Ann Oncol; 1992 Sep; 3 Suppl 4():117-28. PubMed ID: 1450072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac disease following treatment of Hodgkin's disease in children and adolescents.
    Hancock SL; Donaldson SS; Hoppe RT
    J Clin Oncol; 1993 Jul; 11(7):1208-15. PubMed ID: 8315419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second cancer among long-term survivors from Hodgkin's disease.
    Nyandoto P; Muhonen T; Joensuu H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):373-8. PubMed ID: 9788418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation.
    Salloum E; Doria R; Schubert W; Zelterman D; Holford T; Roberts KB; Farber LR; Kiehl RK; Cardinale J; Cooper DL
    J Clin Oncol; 1996 Sep; 14(9):2435-43. PubMed ID: 8823321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood.
    van Leeuwen FE; Klokman WJ; Veer MB; Hagenbeek A; Krol AD; Vetter UA; Schaapveld M; van Heerde P; Burgers JM; Somers R; Aleman BM
    J Clin Oncol; 2000 Feb; 18(3):487-97. PubMed ID: 10653864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease.
    Hancock SL; Tucker MA; Hoppe RT
    JAMA; 1993 Oct; 270(16):1949-55. PubMed ID: 8411552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.
    Swerdlow AJ; Douglas AJ; Hudson GV; Hudson BV; Bennett MH; MacLennan KA
    BMJ; 1992 May; 304(6835):1137-43. PubMed ID: 1392790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age.
    Abrahamsen JF; Andersen A; Hannisdal E; Nome O; Abrahamsen AF; Kvaløy S; Høst H
    J Clin Oncol; 1993 Feb; 11(2):255-61. PubMed ID: 8426202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of second lung cancer in Hodgkin's lymphoma survivors: a meta-analysis.
    Ibrahim EM; Kazkaz GA; Abouelkhair KM; Al-Mansour MM; Al-Fayea TM; Al-Foheidi M; Bayer AM; Elmasri OA
    Lung; 2013 Feb; 191(1):117-34. PubMed ID: 23053567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease.
    Aisenberg AC; Finkelstein DM; Doppke KP; Koerner FC; Boivin JF; Willett CG
    Cancer; 1997 Mar; 79(6):1203-10. PubMed ID: 9070499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.
    Travis LB; Gospodarowicz M; Curtis RE; Clarke EA; Andersson M; Glimelius B; Joensuu T; Lynch CF; van Leeuwen FE; Holowaty E; Storm H; Glimelius I; Pukkala E; Stovall M; Fraumeni JF; Boice JD; Gilbert E
    J Natl Cancer Inst; 2002 Feb; 94(3):182-92. PubMed ID: 11830608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.